Showing results 13 to 32 of 35
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2020 | Genomic analysis of fluoroquinolone-susceptible phylogenetic group B2 extraintestinal pathogenic Escherichia coli causing infections in cats | Kidsley, A.K.; O'Dea, M.; Ebrahimie, E.; Mohammadi Dehcheshmeh, M.; Saputra, S.; Jordan, D.; Johnson, J.R.; Gordon, D.; Turni, C.; Djordjevic, S.P.; Abraham, S.; Trott, D.J. |
| 2020 | Genomic analysis of phylogenetic group B2 extraintestinal pathogenic E. coli causing infections in dogs in Australia | Kidsley, A.K.; O'Dea, M.; Saputra, S.; Jordan, D.; Johnson, J.R.; Gordon, D.M.; Turni, C.; Djordjevic, S.P.; Abraham, S.; Trott, D.J. |
| 2019 | Genomic and functional analysis of emerging virulent and multidrug-resistant Escherichia coli lineage sequence type 648 | Schaufler, K.; Semmler, T.; Wieler, L.H.; Trott, D.J.; Pitout, J.; Peirano, G.; Bonnedahl, J.; Dolejska, M.; Literak, I.; Fuchs, S.; Ahmed, N.; Grobbel, M.; Torres, C.; McNally, A.; Pickard, D.; Ewers, C.; Croucher, N.J.; Corander, J.; Guenther, S. |
| 2018 | Gram-positive and gram-negative antibiotic activity of asymmetric and monomeric robenidine analogues | Russell, C.C.; Stevens, A.; Pi, H.; Khazandi, M.; Ogunniyi, A.; Young, K.A.; Baker, J.R.; McCluskey, S.N.; Page, S.W.; Trott, D.J.; McCluskey, A. |
| 2020 | High-resolution melting curve analysis: a novel method for identification of Mycoplasma species isolated from clinical cases of bovine and porcine respiratory disease | Ahani Azari, A.; Amanollahi, R.; Jafari Jozani, R.; Trott, D.J.; Hemmatzadeh, F. |
| 2022 | Impact of a novel anticoccidial analogue on systemic staphylococcus aureus infection in a bioluminescent mouse model | Nguyen, H.T.; Venter, H.; Woolford, L.; Young, K.; McCluskey, A.; Garg, S.; Page, S.W.; Trott, D.J.; Ogunniyi, A.D. |
| 2022 | In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens | Pi, H.; Venter, H.; Russell, C.C.; Young, K.A.; McCluskey, A.; Page, S.W.; Ogunniyi, A.D.; Trott, D.J. |
| 2019 | In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa | Chan, W.Y.; Hickey, E.E.; Khazandi, M.; Page, S.W.; Trott, D.J.; Hill, P.B. |
| 2019 | In vitro antimicrobial activity of robenidine, ethylenediaminetetraacetic acid and polymyxin B nonapeptide against important human and veterinary pathogens | Khazandi, M.; Pi, H.; Chan, W.Y.; Ogunniyi, A.D.; Sim, J.X.F.; Venter, H.; Garg, S.; Page, S.W.; Hill, P.B.; McCluskey, A.; Trott, D.J. |
| 2019 | In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa | Chan, W.Y.; Khazandi, M.; Hickey, E.E.; Page, S.W.; Trott, D.J.; Hill, P.B. |
| 2020 | In vitro efficacy and pharmacodynamic profiles of four polyether ionophores against methicillin-resistant Staphylococcus spp. | Hickey, E.E.; Page, S.W.; Trott, D.J. |
| 2016 | Isolation of mecC MRSA in Australia | Worthing, K.A.; Coombs, G.W.; Pang, S.; Abraham, S.; Saputra, S.; Trott, D.J.; Jordan, D.; Wong, H.S.; Abraham, R.J.; Norris, J.M. |
| 2015 | Marsupial oral cavity microbiome | Bird, P.S.; Boardman, W.S.J.; Trott, D.J.; Blackall, L.L. |
| 2018 | Methicillin-resistant staphylococci amongst veterinary personnel, personnel-owned pets, patients and the hospital environment of two small animal veterinary hospitals | Worthing, K.A.; Brown, J.; Gerber, L.; Trott, D.J.; Abraham, S.; Norris, J.M. |
| 2018 | Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from Australian animals and veterinarians | Worthing, K.A.; Abraham, S.; Pang, S.; Coombs, G.W.; Saputra, S.; Jordan, D.; Wong, H.S.; Abraham, R.J.; Trott, D.J.; Norris, J.M. |
| 2016 | Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from Australian veterinarians | Groves, M.D.; Crouch, B.; Coombs, G.W.; Jordan, D.; Pang, S.; Barton, M.D.; Giffard, P.; Abraham, S.; Trott, D.J.; Becker, K. |
| 2023 | Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model | Nguyen, H.T.; Venter, H.; Woolford, L.; Young, K.A.; McCluskey, A.; Garg, S.; Sapula, S.S.; Page, S.W.; Ogunniyi, A.; Trott, D.J.; Leggett, J.E. |
| 2019 | Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64, a new disseminated multidrug-resistant commensal and extraintestinal pathogen | Johnson, J.R.; Johnston, B.D.; Porter, S.B.; Clabots, C.; Bender, T.L.; Thuras, P.; Trott, D.J.; Cobbold, R.; Mollinger, J.; Ferrieri, P.; Drawz, S.; Banerjee, R.; Diekema, D.J. |
| 2021 | Repurposing of the fasciolicide triclabendazole to treat infections caused by staphylococcus spp. and vancomycin-resistant enterococci | Pi, H.; Ogunniyi, A.D.; Savaliya, B.; Nguyen, H.T.; Page, S.W.; Lacey, E.; Venter, H.; Trott, D.J. |
| 2017 | Reverse zoonotic transmission of community-associated MRSA ST1-IV to a dairy cow | Abraham, S.; Jagoe, S.; Pang, S.; Coombs, G.W.; Pang, S.; Coombs, G.W.; O'Dea, M.; Kelly, J.; Trott, D.J. |